To the full analysis
Sumitomo Chemical stock: growth
4005.TSumitomo Chemical reported $14.58B in revenue for fiscal 2026, down 10.7% on the prior year, up 0.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
1.4%
per year from 2007 to 2026, per share 1.4%
Earnings (Annual rate)
−2.2%
per year from 2007 to 2026, per share −2.2%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 0.4% | 1.0% | 1.4% |
| Revenue per share | 0.3% | 1.0% | 1.4% |
| Earnings | 5.8% | −2.9% | −2.2% |
| Earnings per share | 5.7% | −2.9% | −2.2% |
| Free cash flow | −14.9% | −4.1% | no data |
| Free cash flow per share | −15.0% | −4.1% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $11.21B | $587.74M | −$87.71M |
| 2008 | $11.88B | $395.02M | $184.69M |
| 2009 | $11.2B | −$370.48M | −$377.66M |
| 2010 | $10.15B | $92.19M | $83.6M |
| 2011 | $12.41B | $153M | $473.71M |
| 2012 | $12.2B | $34.99M | −$75.7M |
| 2013 | $12.23B | −$319.83M | $311.75M |
| 2014 | $14.05B | $231.55M | $253.29M |
| 2015 | $14.88B | $326.82M | $1.05B |
| 2016 | $13.16B | $510.04M | $1.07B |
| 2017 | $12.14B | $479.28M | $299.24M |
| 2018 | $13.72B | $837.64M | $901.98M |
| 2019 | $14.52B | $738.85M | $208.69M |
| 2020 | $13.94B | $193.65M | −$90.4M |
| 2021 | $14.32B | $288.32M | $1.59B |
| 2022 | $17.32B | $1.02B | $402.31M |
| 2023 | $18.13B | $43.75M | −$200.13M |
| 2024 | $15.32B | −$1.95B | −$1.28B |
| 2025 | $16.32B | $241.65M | $642.23M |
| 2026 | $14.58B | $381.64M | $708.8M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 2 Jan 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.